Evidence map›Paper›PMID 30676207›Full record

ArticleRNA biology2019

Dual Laplacian regularized matrix completion for microRNA-disease associations prediction.

Chang Tang, Hua Zhou, Xiao Zheng, Yanming Zhang, Xiaofeng Sha

Abstract read
In one paragraph

Article in RNA biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Chang Tanga School of Computer Science , China University of Geosciences , Wuhan , China.
Hua Zhoub Department of Hematology , The Affiliated Huai'an Hospital of Xuzhou Medical University , Huai'an , China.
Xiao Zhengc Wuhan University of Technology Hospital , Wuhan University of Technology , Wuhan , China.
Yanming Zhangb Department of Hematology , The Affiliated Huai'an Hospital of Xuzhou Medical University , Huai'an , China.
Xiaofeng Shad Department of Oncology , Huai'an Hongze District People's Hospital , Huai'an , China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Since lots of miRNA-disease associations have been verified, it is meaningful to discover more miRNA-disease associations for serving disease diagnosis and prevention of human complex diseases. However, it is not practical to identify potential associations using traditional biological experimental methods since the process is expensive and time consuming. Therefore, it is necessary to develop efficient computational methods to accomplish this task. In this work, we introduced a matrix completion model with dual Laplacian regularization (DLRMC) to infer unknown miRNA-disease associations in heterogeneous omics data. Specifically, DLRMC transformed the task of miRNA-disease association prediction into a matrix completion problem, in which the potential missing entries of the miRNA-disease association matrix were calculated, the missing association can be obtained based on the prediction scores after the completion procedure. Meanwhile, the miRNA functional similarity and the disease semantic similarity were fully exploited to serve the miRNA-disease association matrix completion by using a dual Laplacian regularization term. In the experiments, we conducted global and local Leave-One-Out Cross Validation (LOOCV) and case studies to evaluate the efficacy of DLRMC on the Human miRNA-disease associations dataset obtained from the HMDDv2.0 database. As a result, the AUCs of DLRMC is 0.9174 and 0.8289 in global LOOCV and local LOOCV, respectively, which significantly outperform a variety of previous methods. In addition, in the case studies on four significant diseases related to human health including Colon Neoplasms, Kidney neoplasms, Lymphoma and Prostate neoplasms, 90%, 92%, 92% and 94% out of the top 50 predicted miRNAs has been confirmed, respectively.

Indexed as

AlgorithmsColonic NeoplasmsComputational BiologyComputer SimulationEarly DiagnosisFemaleGenetic Predisposition to DiseaseHumansKidney NeoplasmsLymphomaMaleMicroRNAsPrognosisProstatic NeoplasmsSensitivity and SpecificityMicroRNAsLaplacian regularizationmatrix completionmicroRNAmiRNA-disease association prediction

Identifiers

PMID30676207
PMCPMC6546388

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.